Sageretia thea
Sageretia thea · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Sageretia thea is a botanical species known for its diverse therapeutic potential in traditional and modern medicine. The plant's leaves and roots contain significant bioactive compounds, including beta-sitosterol, daucosterol, friedeline, and gluco-syringic acid. Researchers utilize various preparations for study, such as leaf extracts (STL), branches (ST-B/STB), and specialized IONPs. These chemical constituents contribute to the plant's documented activities, most notably its anticancer properties. Furthermore, the species is frequently investigated for its ability to address medicinal conditions like fevers and hepatitis.
- Synonyms
- Rhamnus Thea
- Common names
- Not available
- Family
- Rhamnaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Common Names
Sageretia thea is a versatile plant recognized by a variety of descriptive common names across different regions. It is most frequently referred to as Hedge Sageretia or simply sageretia in many gardening circles. In English-speaking contexts, it is also widely known as Pauper's-tea. The plant's identity is further reflected in its Russian name, Сажереция ярко-зеленая. Understanding these various names helps enthusiasts identify this unique species regardless of the terminology used.
Sources: Catalogue of Life (COL)
Synonyms
Sageretia thea is a plant species that is frequently identified in botanical literature through its alternative taxonomic name. This specific organism is also recognized by the synonym Rhamnus thea, reflecting historical shifts in its classification. Understanding these naming variations is essential for researchers tracking the plant's lineage and distribution. By recognizing both terms, botanists can ensure accuracy when studying its unique biological characteristics. Consequently, navigating these synonymous relationships provides a clearer picture of the species' place within the natural world.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Sageretia thea is a distinctive botanical specimen that belongs to the vast kingdom Plantae. Within this expansive group, it is classified under the class Equisetopsida. Its taxonomic journey continues through the order Rosales, showcasing its evolutionary connections. The plant is further categorized into the specific genus Sageretia. Finally, it finds its place within the Rhamnaceae family, completing its unique biological profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Rhamnaceae |
| Genus | Sageretia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Sageretia thea is a resilient species with a diverse geographic distribution spanning across two major regions. In Africa, it is primarily found within the Northeast Tropical zone, specifically inhabiting Eritrea, Ethiopia, and Somalia. The plant also extends its reach into the Asia-Temperate region, where it thrives within the Arabian Peninsula. Within these Gulf States, its presence is notable in countries such as Oman. This wide-ranging habitat highlights the plant's ability to adapt to various environmental conditions across different continents.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Sageretia thea is a self-supporting plant that typically takes on a shrub-like growth form. Depending on its environment, this species can reach a modest height of 1.5 meters. In some optimal conditions, however, it is capable of growing up to a maximum height of 3 meters. This versatile structure makes it a flexible addition to various landscape designs.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Sageretia thea, commonly referred to as Chinese sweet plum or Chinese bird plum, is a plant with a rich history of medicinal use in Korea and China. While it has traditionally been utilized to treat fevers and hepatitis, modern research highlights a much broader range of biological benefits. Notably, the plant has been reported to exert significant anticancer activity alongside its antioxidant properties. Recent studies further expand this profile by demonstrating its ability to inhibit inflammation through specific signaling pathways. These diverse therapeutic characteristics suggest that the plant holds great potential for the development of various medicinal treatments.
Compounds
Sageretia thea is a plant species characterized by a diverse profile of chemical constituents. Detailed analysis reveals that the plant contains several important compounds, including beta-sitosterol and daucosterol. Additionally, the presence of friedeline has been identified through spectral data and physico-chemical constants. The plant also serves as a source for syringic acid, a notable organic compound. Furthermore, researchers have confirmed that Sageretia thea contains gluco-syringic acid, marking a significant finding for its chemical characterization.
Conditions
Sageretia thea has been traditionally utilized in Korea and China for its medicinal ability to treat hepatitis and fevers. The plant also demonstrates significant biological activity, such as its ability to treat DPPH through strong anti-radical scavenging potential. Research into its extracts has revealed that Sageretia thea can treat HIV type 1 protease (PR) by showing inhibitory effects on the enzyme. Additionally, the plant exhibits antibacterial properties, particularly when used as a bio-template for synthesizing iron oxide nanoparticles. These diverse therapeutic relationships highlight the plant's broad range of potential medicinal applications.
Preparations
Sageretia thea is utilized in various forms, including as a bio-template for the preparation of iron oxide nanoparticles (IONPs). The plant is also prepared as extracts from the leaves (STL/ST-L) and as branches (ST-B/STB) to study their biological effects. These leaf extracts (ST-L) and branch preparations (ST-B) have demonstrated significant anti-inflammatory properties by suppressing NF-κB and MAPK signaling pathways. Furthermore, the leaf extracts (STL) and branch preparations (STB) are used to investigate anticancer activities, specifically their ability to reduce cell viability in colorectal cancer cells. Together, these different preparations of Sageretia thea serve as essential components in researching sustainable nanotechnology and potential therapeutic drug development.
Parts used
Sageretia thea is a medicinal plant recognized for its diverse therapeutic properties, including anti-inflammatory and anticancer activities. Research has specifically highlighted the effectiveness of extracts derived from its leaves in suppressing pro-inflammatory mediators and inducing apoptosis in cancer cells. Beyond its foliage, the plant's leaves have also demonstrated potential in inhibiting the HIV-1 protease enzyme. Additionally, the roots of Sageretia thea serve as a valuable bio-template for the green synthesis of iron oxide nanoparticles. These nanoparticles, created using root extracts, exhibit significant antibacterial, antifungal, and antioxidant potentials for various biological applications.